a 68930 has been researched along with Dyskinesia, Drug-Induced in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Croke, DT; Fienberg, AA; Grandy, DK; Kinsella, A; Koshikawa, N; Makihara, Y; Nally, RE; O'Sullivan, G; Sibley, DR; Tighe, O; Tomiyama, K; Waddington, JL; Yamamoto, H | 1 |
1 other study(ies) available for a 68930 and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction 'knockout'.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Chromans; Dopamine and cAMP-Regulated Phosphoprotein 32; Dyskinesia, Drug-Induced; Mice; Mice, Congenic; Mice, Inbred C57BL; Mice, Knockout; Receptors, Dopamine D4; Receptors, Dopamine D5; Signal Transduction | 2006 |